Anavex Life Sciences Corp.
Category
General Information
Locality: New York, New York
Phone: +1 844-689-3939
Address: 51 W 52nd St 10019 New York, NY, US
Website: anavex.com
Likes: 977
Reviews
Facebook Blog
Anavex Life Sciences to Present at Upcoming Global Healthcare Conferences Cantor Fitzgerald Global Healthcare Conference 2020 and H.C. Wainwright 22nd Annual Global Investment Conference https://bit.ly/2VLEB2q... #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces Commitment for Financial Investment by Shake It Up Foundation for Parkinson’s Research for Clinical Trial of ANAVEX2-73 (Blarcamesine) in Patients with Parkinson’s Disease https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Reports Fiscal 2020 Third Quarter Financial Results And Provides Business Updates https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX2-73 (blarcamesine) for Alzheimer’s Disease Patients https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences to Announce Fiscal 2020 Third Quarter Financial Results on Thursday, August 6th, 2020 Conference Call and Webcast To be Held Thursday, August 6, 2020 11:00 am Eastern Time https://bit.ly/2VLEB2q... #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces First Participant Enrolled in Phase 1 Study of ANAVEX3-71 (AF710B) https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces First Patient Dosed in EXCELLENCE Phase 2/3 Clinical Trial of ANAVEX2-73 (Blarcamesine) in Patients with Rett Syndrome https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces Exceeding of Enrollment Target for the ANAVEX2-73 (blarcamesine) U.S. Phase 2 Rett Syndrome Clinical Trial https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX3-71 (AF710B) https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business Updates https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020 https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Announces Publication of Clinical Data for ANAVEX2-73 (blarcamesine) in Alzheimer’s Disease https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Anavex Life Sciences Provides Update on Clinical Program Development as Response to COVID-19 https://bit.ly/2VLEB2q #COVID19 #RettSyndrome #rett #rettawareness #biotech #publiccompany #Alzh #PDD #coronavirus
Popular Listings
Safe & Sane Driving School
140 McLean Ave 10705 Yonkers, NY, US
+1 914-476-9100
School, Campus building, Driving school
RIT ECT Engineering Technology
78 Lomb Memorial Dr, # 82-2110 14623 Rochester, NY, US
+1 585-475-2179
College & University, Engineering service, Campus building
SUNY Upstate MD/PhD Program
750 E Adams St 13210 Syracuse, NY, US
+1 315-464-4543
School, College & University, Campus building